“
“The aim of this study was to assess complications and short-term results (3 months and 1 year) from a single-incision mid-urethral tape for stress urinary incontinence.
Seventy-four women underwent single-incision mid-urethral tape under local anaesthesia, 59 of whom completed a 1-year follow-up. Selleck LGX818 Thirty-seven (50%) suffered urodynamic stress urinary incontinence. The International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) was completed in the context of the case
history pre-operatively and post-operatively. The duration of follow-up ranged from 91 to 466 days.
The use of MiniArc (TM) tape in our study resulted in the objective cure rate (negative cough stress test) of 74% and 66% at 3 months and 1 year, respectively. Scores with ICIQ-SF questionnaire improved significantly at 3 months and 1 year (p < 0.0001). No major
intra-operative complication was reported in our study.
Despite the advantage AZD0530 solubility dmso of being done under local anaesthetic, the overall cure rate is 66% at 1 year.”
“Study Design. Case study.
Objective. The study presents a complication that is thought to have never before been reported with this therapeutic intervention. Results from this report are discussed with intentions to inform the neurosurgery, spine and pain management community of an additional complication associated with spinal cord stimulation (SCS).
Summary of Background Data. SCS is a common intervention used to treat refractory neuropathic pain. Complications from this procedure are uncommon, but they do occur.
Methods. A unique complication of SCS was identified and treated. A search of the entire PubMed/Medline C59 Wnt Stem Cells & Wnt inhibitor database failed to find any similar such complication.
Results. An epidural mass which caused
significant cervical stenosis and spinal cord compression at the site of a previous SCS electrode was identified. Decompressive laminectomies and resection of the mass were performed. The mass was characterized as fibrous tissue with foreign body giant cell reaction.
Conclusion. This is a unique complication of SCS about which all professionals evaluating patients who have similar implanted devices, even if they have already been removed, should be made aware of.”
“This prospective multicenter study was conducted to evaluate the efficacy and safety of an adjustable mid-urethral sling (MUS) using transobturator adjustable tape (TOA) in women with severe stress urinary incontinence or combined stress urinary incontinence (SUI) and voiding dysfunction (VD).
One day after placement of TOA, the tension was adjusted. Six months after surgery, changes in several questionnaires and uroflowmetry (UFM) parameters were evaluated.
Among the 65 women enrolled in the study, 27 (41.5%) required postoperative tension readjustments. At 6 months, the complete cure rate of SUI was 84.